Launch HN: RonanRX (YC S26) – Personalized Peptides and GLP-1s

RonanRx, founded by former mask-manufacturing entrepreneur Lloyd, integrates software-driven prescribing, telehealth, compounding, manufacturing, and delivery to produce personalized GL-1 and peptide therapies, using patient data and wearables to create a closed-loop treatment workflow. By owning the full stack from molecule to distribution, the company claims drug prices 3-10 × lower than traditional channels while enabling dose customization based on individual response.